Neuroendocrine Tumors
📧 Sign up to get email alerts when something new happens for Neuroendocrine Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-12-15Clinical Trial Update: Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs) [Phase 2]
Phase II study of a subcutaneous depot formulation of octreotide in acromegaly and neuroendocrine tumors has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-10-12Clinical Trial Update: 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors [Phase 1]
This update reports progress on a Phase 1 trial of the radiopharmaceutical 177Lu-DOTA-EB-TATE in patients with advanced neuroendocrine tumor…
-
CLINICAL_TRIALS trial_result · 2017-09-12Clinical Trial Update: Study to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Tumor [Phase 2]
Phase 2 trial comparing capecitabine with dacarbazine vs capecitabine with temozolomide in advanced/metastatic gastrointestinal, pancreatic,…
-
CLINICAL_TRIALS trial_result · 2017-07-17Clinical Trial Update: Study of Panobinostat in Patients With Neuroendocrine Tumors [Phase 2]
Phase 2 trial of panobinostat in patients with neuroendocrine tumors was terminated; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Lithium for Low-Grade Neuroendocrine Tumors [Phase 2]
Phase 2 clinical trial evaluating lithium for low-grade neuroendocrine tumors has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: Phase 2a Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors [Phase 2]
A Phase 2a trial of desipramine in small cell lung cancer and other high-grade neuroendocrine tumors was terminated, with results posted in …
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors [Phase 2]
Phase II study of pertuzumab in combination with erlotinib for metastatic or unresectable neuroendocrine tumors was terminated, with results…
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
A clinical trial evaluating perfusion CT to predict treatment response in hepatic malignancies has been terminated; the update does not repo…
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: Combination Targeted Radiotherapy in Neuroendocrine Tumors [NA]
This document reports a completed clinical trial evaluating combination targeted radiotherapy in neuroendocrine tumors.
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: Capecitabine and Temozolomide for Neuroendocrine Cancers [Phase 2]
Phase 2 trial evaluating the combination of capecitabine and temozolomide in neuroendocrine tumors has completed with results posted in 2016…
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors [Phase 3]
A Phase 3 trial evaluating systemic therapy with or without upfront transarterial embolization for inoperable liver metastases from neuroend…
-
CLINICAL_TRIALS trial_result · 2016-03-30Clinical Trial Update: RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation [Phase 4]
A Phase 4 trial evaluating everolimus (RAD001) in combination with paclitaxel and carboplatin as first-line therapy for advanced large cell …
-
CLINICAL_TRIALS trial_result · 2015-09-03Clinical Trial Update: Imaging of Neuroendocrine Tumors With PET and Fluoro-18-DOPA (F-DOPA) [NA]
This clinical trial update reports on imaging neuroendocrine tumors using PET with the radiotracer Fluoro-18-DOPA (F-DOPA); the study status…
-
CLINICAL_TRIALS trial_result · 2015-08-07Clinical Trial Update: DOTA-TOC in Metastasized Neuroendocrine Tumors [Phase 2]
This document reports the completion of a Phase 2 trial evaluating DOTA-TOC in metastasized neuroendocrine tumors.
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors [Phase 2]
A Phase 2 trial assessing predictive biomarkers of response to sunitinib in poorly differentiated neuroendocrine tumors; the study was termi…
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases [Phase 2]
Phase 2 trial update of Yttrium-90 glass microsphere radioembolization (TheraSphere) for patients with liver metastases, completed with resu…
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating bevacizumab with temozolomide in neuroendocrine tumors has completed enrollment. The document does not report trial…
-
CLINICAL_TRIALS trial_result · 2011-03-28Clinical Trial Update: Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut [Phase 3]
Phase 3 trial evaluating antiproliferative effect of octreotide in patients with metastasized midgut neuroendocrine tumors has completed wit…
-
CLINICAL_TRIALS trial_result · 2010-09-16Clinical Trial Update: Bevacizumab Plus Somatostatin Analogue and Metronomic Capecitabine in Patients With Advanced Neuroendocrine Tumors [Phase 2]
Phase 2 trial evaluating the combination of bevacizumab, a somatostatin analogue, and metronomic capecitabine in patients with advanced neur…
-
CLINICAL_TRIALS trial_result · 2010-08-12Clinical Trial Update: Pemetrexed in Patients With Advanced Neuroendocrine Tumors [Phase 2]
This clinical trial update reports the completion of a Phase 2 trial evaluating pemetrexed in patients with advanced neuroendocrine tumors.
-
CLINICAL_TRIALS trial_result · 2009-08-06Clinical Trial Update: 5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors [Phase 2]
A Phase 2 trial evaluating 5-fluorouracil in combination with Octreotide Long-Acting Release for neuroendocrine tumors has completed.
-
CLINICAL_TRIALS trial_result · 2008-07-21Clinical Trial Update: Treatment With SU11248 in Patients With Neuroendocrine Tumors [Phase 2]
Phase 2 trial of SU11248 (sunitinib) in patients with neuroendocrine tumors has completed.
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia [Phase 2]
Phase 2 trial of complete cytoreductive surgery with intraperitoneal chemohyperthermia for cancers involving the peritoneum was terminated; …